Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by malibukion Dec 19, 2017 6:36pm

86 Views

Post# 27191461

timing and content of the update

Any deal can drop I can understand that but having this update right after the AGM is not a honest move. This was the news being expected for years and should have been released before the AGM and then shareholders should have decided to fire HV or not. You can not say "deal is dead for near term" at the next day of the AGM and keep the seat and the salary. Shareholders did not vote the same company 1 month ago, now Sirona is a different company.

Also Kevin Green worked in Alllergan for derma acqusitions until Jan 2017 (look Linkedin bio down). I think he was the one made the contact and somehow it did not go further after he left. Then why one should belive that his presence will change anything? He was the guy before and the deal did not happen.

Managing Director

Company Name

Dates EmployedJan 2017 – Present

Employment Duration1 yr

BioMed Advisory, LLC is a strategic consulting firm, providing service for the pharmaceuticals, biotechnology, and medical devices industries. I focus on providing general strategy and business development consulting services, with a particular emphasis on strategic advisory and transaction activities.

Senior Director, Business Development

Company Name

Dates EmployedJun 2006 – Jan 2017

Employment Duration10 yrs 8 mos

Charged with growing the dermatology and aesthetics businesses through licensing and acquisitions. Identify and fill gaps in portfolio by finding and evaluating potential targets and completing transactions.

• Work with internal stakeholders to develop strategies and priorities for business development and growth
• Negotiate business development transactions including partnerships, licenses, and mergers and acquisitions
• Oversee due diligence for select opportunities
• Build valuation models to assist in deal structure and determine financial impact of a transaction

Previous work included financial analysis work supporting the business development efforts of Allergan. This included financial modeling of potential licensing and M&A transactions, accretion/dilution studies, DCF and other valuation methods. Additional work involved assisting in due diligence efforts and other aspects of the business development process.

Prior work experience at Allergan includes financial analysis in the sales and marketing departments, which included budgeting and forecasting for these divisions.